4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
8.26
-0.16 (-1.90%)
At close: Sep 26, 2025, 11:07 AM
-1.90% (1D)
| Bid | 5.89 |
| Market Cap | 385.74M |
| Revenue (ttm) | 33K |
| Net Income (ttm) | -196.14M |
| EPS (ttm) | -3.53 |
| PE Ratio (ttm) | -2.34 |
| Forward PE | -2.22 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10.4 |
| Volume | 200,773 |
| Avg. Volume (20D) | 1,176,542 |
| Open | 8.31 |
| Previous Close | 8.42 |
| Day's Range | 8.05 - 8.48 |
| 52-Week Range | 2.23 - 11.20 |
| Beta | 2.85 |
| Ex-Dividend Date | n/a |
About FDMT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FDMT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FDMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4D Molecular Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+42.67%
4D Molecular Therapeutics shares are trading highe...
Unlock content with
Pro Subscription
1 month ago
+2.04%
4D Molecular Therapeutics shares are trading higher after the company announced results from its 4D-150 SPECTRA clinical trial.
